Phospho-ATF2 (S62) Antibody

What is the biological significance of ATF2 phosphorylation at serine-62?

ATF2 phosphorylation at serine-62 (S62) represents a critical regulatory modification that influences ATF2's transcriptional activity. Unlike the well-characterized T69/T71 phosphorylation sites that are primarily targeted by stress-activated protein kinases (SAPKs) like p38 and JNK, S62 phosphorylation involves different signaling pathways. Research has shown that vaccinia-related kinase 1 (VRK1) can phosphorylate both T73 and S62, resulting in T73-dependent transcriptional activation . This phosphorylation event is particularly important for ATF2's role in regulating genes involved in stress responses, development, and growth . The S62 phosphorylation appears to work in coordination with other phosphorylation sites to fine-tune ATF2's diverse cellular functions.

How does S62 phosphorylation differ functionally from other ATF2 phosphorylation sites?

ATF2 contains multiple phosphorylation sites that serve distinct functions:

Unlike T69/T71 phosphorylation which primarily activates ATF2's transcriptional function, S62 phosphorylation appears to have a modulatory role that can work independently or synergistically with other phosphorylation events to regulate ATF2's diverse cellular functions . Studies show that S62 phosphorylation can influence ATF2's protein-protein interactions and its ability to trans-activate gene expression in response to stimuli such as 12-O-tetradecanoylphorbol-13-acetate (TPA) .

What are the optimal applications for Phospho-ATF2 (S62) antibody in research?

Based on validated research applications, Phospho-ATF2 (S62) antibody has proven effective in several experimental techniques:

• Western Blot (WB): Highly effective for detecting phosphorylated ATF2 at S62 in cell and tissue lysates. Recommended dilutions range from 1:500-1:2000 . Successfully applied to various cell lines including MCF7, A549, and HeLa cells .

• Immunohistochemistry (IHC): Effective for tissue section analysis with dilutions between 1:50-1:300 . Has been validated on human prostate cancer and breast carcinoma tissue sections .

• Immunoprecipitation (IP): Useful for isolating phosphorylated ATF2 complexes with recommended concentrations of 2-5μg or dilutions of 1:50-1:200 .

• ELISA: Can be used at high dilutions (1:20000) for quantitative analysis .

The choice of application should be determined by your specific research question, with WB providing the most straightforward quantification of phosphorylation levels in response to various stimuli.

What are the most effective methods for studying ATF2 S62 phosphorylation dynamics?

To effectively study the dynamics of ATF2 S62 phosphorylation:

• Time-course experiments: Examine phosphorylation changes following stimulation with known modulators (e.g., UV treatment, viral infection) at multiple time points .

• Mass spectrometry-based phosphoproteomics: For comprehensive analysis of multiple phosphorylation sites simultaneously, quantitative phosphoproteomics using SILAC (Stable Isotope Labeling by Amino acids in Cell culture) or Hybrid-DIA (Data-Independent Acquisition) methods can be employed .

• Pharmacological inhibitors: Use specific inhibitors against potential upstream kinases (e.g., VRK1, PKC inhibitors) to validate the signaling pathways leading to S62 phosphorylation .

• Site-directed mutagenesis: Generate S62A (non-phosphorylatable) or S62D/E (phosphomimetic) mutants to study the functional consequences of this modification .

• Proximity-based labeling: For studying protein interactions dependent on S62 phosphorylation status, BioID or APEX2 approaches coupled with ATF2 mutants can provide valuable insights.

Studies have shown that combining multiple approaches provides the most comprehensive understanding of ATF2 phosphorylation dynamics and functional consequences .

How does ATF2 S62 phosphorylation coordinate with other phosphorylation sites in response to specific stimuli?

ATF2 phosphorylation represents a complex regulatory network that integrates multiple signaling inputs:

• Viral infection: During pseudorabies virus (PRV) infection, ATF2 phosphorylation is significantly increased without changes in total ATF2 expression . The increased phosphorylation promotes viral replication, particularly during viral genome DNA biogenesis.

• DNA damage response: ATF2 phosphorylation at S62 occurs alongside other phosphorylation events. While S490/S498 phosphorylation by ATM is critical for DNA damage response and is independent of T69/T71 phosphorylation , S62 phosphorylation appears to influence ATF2's transcriptional activity during this process.

• MAPK signaling crosstalk: Research has shown that phosphorylation at S90 can negatively affect p38 binding to ATF2 , suggesting that different phosphorylation events create a regulatory code that determines which upstream kinases can interact with ATF2.

The coordination between these sites appears to be stimulus-specific, with some stimuli activating multiple pathways simultaneously while others selectively target specific phosphorylation sites .

What methodological approaches can distinguish between the functions of different ATF2 phosphorylation sites?

To differentiate between the functions of various ATF2 phosphorylation sites:

• Site-specific phospho-antibodies: Use antibodies targeting individual phosphorylation sites (e.g., phospho-S62, phospho-T69/71, phospho-S490) in parallel experiments .

• Phosphosite mutants: Generate ATF2 constructs with mutations at single or multiple phosphorylation sites and compare their functional consequences:

  • S62A (non-phosphorylatable) vs. S62D (phosphomimetic)

  • Combination mutants (e.g., S62A+T69A/T71A) to assess synergistic or antagonistic relationships

• Kinase specificity assays: In vitro kinase assays using purified kinases (VRK1, JNK, p38, ATM) and ATF2 substrate to determine site-specific phosphorylation patterns .

• Temporal analysis: Investigate the timing of different phosphorylation events using synchronized stimulation and time-course analysis .

• Phosphoproteomics: Employ quantitative phosphoproteomics to measure multiple phosphorylation events simultaneously, particularly using targeted approaches like the Hybrid-DIA method .

Research has demonstrated that these approaches can successfully distinguish between different ATF2 functions, such as its role in transcriptional regulation versus DNA damage response .

What are common challenges in detecting ATF2 S62 phosphorylation and how can they be addressed?

Common challenges and solutions include:

Additionally, optimizing protein extraction conditions is crucial. The use of strong phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride, and β-glycerophosphate) in lysis buffers is essential to preserve phosphorylation status during sample preparation .

How can researchers validate the specificity of Phospho-ATF2 (S62) antibody results?

To confirm antibody specificity and validate experimental findings:

• Peptide competition assay: Pre-incubate the antibody with the immunizing phosphopeptide before applying to samples. This should eliminate specific signal .

• Phosphatase treatment: Treat one sample set with lambda phosphatase to remove phosphorylation and confirm loss of signal .

• Genetic approaches: Use ATF2 knockdown (siRNA/shRNA) or knockout (CRISPR-Cas9) cells to confirm signal specificity .

• Mutational analysis: Express ATF2 S62A mutant and confirm loss of antibody recognition .

• Cross-validation: Compare results using alternative detection methods:

  • Independent antibodies from different vendors

  • Mass spectrometry-based phosphosite identification

  • Functional assays correlated with phosphorylation status

Recent studies have employed multiple validation approaches in combination to ensure reliable detection of ATF2 phosphorylation, particularly in complex experimental systems like viral infection models .

How can mass spectrometry be optimized for quantitative analysis of ATF2 S62 phosphorylation?

Mass spectrometry-based approaches for ATF2 phosphorylation analysis can be optimized through:

• Enrichment strategies:

  • TiO₂ or IMAC (Immobilized Metal Affinity Chromatography) for phosphopeptide enrichment

  • Immunoprecipitation with ATF2 antibodies prior to MS analysis

• Quantification approaches:

  • SILAC labeling for relative quantification across experimental conditions

  • Hybrid-DIA for simultaneous targeted and discovery analysis

  • Phosphopeptide-specific MRM (Multiple Reaction Monitoring) for highest sensitivity

• Analytical considerations:

  • Use multiple search algorithms (e.g., InsPecT, SEQUEST, OMSSA) to improve phosphosite identification

  • Apply phosphosite localization algorithms such as Ascore, PhosphoScore, and Phosphate Localization Score

  • Extend peptide coverage through multiple proteases (not just trypsin)

• Validation strategies:

  • Targeted Ion Selection (TIS) for confirmation of data-dependent quantification

  • Apply phosphorylation motif analysis tools like motif-x algorithm to identify consensus patterns

A comprehensive workflow should include computational analysis steps as outlined in studies using quantitative phosphoproteomics approaches .

What experimental designs best capture the functional consequences of ATF2 S62 phosphorylation?

To effectively study the functional impact of ATF2 S62 phosphorylation:

• Genetic engineering approaches:

  • Generate stable cell lines expressing ATF2 wild-type, S62A (non-phosphorylatable), or S62D/E (phosphomimetic) mutants

  • Use CRISPR-Cas9 to introduce point mutations at the endogenous ATF2 locus

  • Employ inducible expression systems to control timing of mutant expression

• Transcriptional activity assessment:

  • Luciferase reporter assays with ATF2-responsive promoters

  • ChIP-seq to identify genome-wide binding changes dependent on S62 phosphorylation status

  • RNA-seq to determine genes differentially regulated by ATF2 S62 phosphorylation status

• Protein interaction studies:

  • IP-MS to identify interaction partners dependent on S62 phosphorylation

  • Proximity labeling techniques (BioID, APEX) coupled with phospho-mutant ATF2

  • FRET-based sensors to monitor ATF2 conformation changes following phosphorylation

• Cellular response assessment:

  • Challenge cells with stress stimuli (viral infection, DNA damage, oxidative stress)

  • Monitor cell fate decisions (proliferation, differentiation, apoptosis)

  • Track subcellular localization changes using phospho-specific antibodies or tagged ATF2 variants

Research has shown that ATF2 phosphorylation affects its interaction with the MRN complex during DNA damage response and its transcriptional activity during viral infection , providing models for experimental design.

How does ATF2 S62 phosphorylation contribute to disease processes?

ATF2 S62 phosphorylation has been implicated in several pathological contexts:

Research using phospho-specific antibodies against ATF2 S62 has enabled the detection of this modification in pathological tissue samples, though functional studies directly linking S62 phosphorylation to disease mechanisms remain an active area of investigation .

What recent advances have improved our understanding of ATF2 phosphorylation dynamics?

Recent methodological advances have significantly enhanced our understanding of ATF2 phosphorylation:

• Quantitative phosphoproteomics: The application of SILAC and Hybrid-DIA methodologies has allowed for systematic analysis of thousands of phosphorylation events simultaneously, placing ATF2 phosphorylation in the broader cellular signaling context .

• Structural insights: Studies have revealed how phosphorylation affects ATF2 binding to partners like p38 MAPK, with structural data showing that ATF2 contains a FENEF motif (residues 92-96) that is crucial for p38 binding, while JNK binding depends on the Zn-finger+D-motif module .

• Multi-site phosphorylation analysis: Advanced techniques have demonstrated how different ATF2 phosphorylation sites work together as a "phosphoswitch" that determines binding partner selectivity :

  • S90 phosphorylation negatively affects p38 binding

  • The 92-FENEF-96 motif is critical for p38-mediated phosphorylation but not JNK-mediated phosphorylation

• Temporal dynamics: Time-course experiments using phospho-specific antibodies have revealed the sequential nature of different ATF2 phosphorylation events in response to stimuli .

These advances have shifted our understanding from viewing ATF2 phosphorylation as isolated events to recognizing it as a complex, integrated signaling code that determines ATF2's diverse cellular functions.

What emerging technologies might enhance the study of ATF2 S62 phosphorylation?

Several emerging technologies hold promise for advancing ATF2 phosphorylation research:

• Phospho-specific biosensors: Development of FRET-based sensors specific for ATF2 S62 phosphorylation would enable real-time monitoring of phosphorylation dynamics in living cells.

• CRISPR-based genomic engineering: Base editing or prime editing technologies could enable precise modification of endogenous ATF2 to create phospho-mutants without disrupting gene expression levels.

• Single-cell phosphoproteomics: Adapting mass spectrometry techniques for single-cell analysis would reveal cell-to-cell variability in ATF2 phosphorylation states within heterogeneous populations.

• Spatial proteomics: Combining phospho-specific antibodies with imaging mass cytometry or multiplexed ion beam imaging could reveal the subcellular localization patterns of differently phosphorylated ATF2 forms.

• Computational modeling: Integration of quantitative phosphorylation data into systems biology models could predict how different combinations of ATF2 phosphorylation events influence cellular outcomes.

These technologies would address current limitations in temporal resolution, cellular heterogeneity assessment, and the ability to monitor multiple phosphorylation events simultaneously in intact cellular systems.

What are the most significant unanswered questions regarding ATF2 S62 phosphorylation?

Despite significant progress, several critical questions remain:

• Kinase specificity: While VRK1 has been identified as one kinase that can phosphorylate S62 , the complete set of kinases capable of targeting this site under different cellular conditions remains incompletely characterized.

• Phosphatase regulation: The phosphatases responsible for removing the S62 phosphorylation mark and the signals that activate them are largely unknown.

• Crosstalk mechanisms: How S62 phosphorylation influences or is influenced by other ATF2 post-translational modifications (other phosphorylation sites, acetylation, ubiquitination, etc.) requires further investigation.

• Temporal dynamics: The precise order of phosphorylation events on ATF2 and whether certain sites serve as priming sites for others remains unclear.

• Therapeutic targeting: Whether modulation of ATF2 S62 phosphorylation could serve as a therapeutic strategy in contexts such as viral infection or cancer requires additional research.

Addressing these questions will require integrated approaches combining biochemical, genetic, structural, and systems biology methodologies to fully understand this complex regulatory mechanism.